• Wed, March 9, 2016
  • Fri, March 11, 2016
  • Sun, March 13, 2016
  • Mon, March 14, 2016
  • Tue, March 15, 2016
  • Thu, March 10, 2016

Konstantinos Aprilakis Maintained (BPMC) at Buy with Decreased Target to $37 on, Mar 9th, 2016

Konstantinos Aprilakis of JMP Securities, Maintained "Blueprint Medicines Corporation" (BPMC) at Buy with Decreased Target from $54 to $37 on, Mar 9th, 2016.

Konstantinos, nor any peers, have made any analyst calls on BPMC in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Like: 👍